Subject: Clearance of the concentration concerning the acquisition by IMITHEA SA of sole control over certain assets of EUROMEDICA SA and its parent companies
Subject: Approval of the acquisition of joint control by the companies “STRIX ASSET MANAGEMENT LTD” and “FARALLON CAPITAL MANAGEMENT L.L.C.” over “EUROMEDICA HEALTHCARE SERVICES S.A.”
Subject: Clearance by the Hellenic Competition Commission of the concentration concerning the acquisition of joint control by the companies (a) FARALLON CAPITAL MANAGEMENT LLC, through the company “HEALTHCARE INVESTORS II (GREECE) LLC” and (b) PIRAEUS BANK SA, over parts of the assets and liabilities of the company EUROMEDICA SA.
Decision on the concentration concerning the acquisition of joint control by the companies (a) FARALLON CAPITAL MANAGEMENT LLC, through the company “HEALTHCARE INVESTORS II (GREECE) LLC” and (b) PIRAEUS BANK SA, over parts of the assets and liabilities of the company EUROMEDICA SA.
For any question you want to ask about the sector inquiry and for more information, contact us by the following email address medinsur@epant.gr or directly the inquiry team:
It is reminded that based on article 41 par. 2 of law 3959/2011, as in force, without prejudice to the provision of article 37 paragraph 2 of the Code of Criminal Procedure, the employees HCC's Directorate-General for Competition are obliged to keep confidentiality regarding confidentially details of companies, business associations or other natural or legal persons, which they receive on the occasion of their service (such as sales, prices, suppliers, trade policies, etc.). Similar provisions are provided by Treatment of confidential information
AnyPersonal Data sent to HCC will be used exclusively for the promotion, support and implementation of the HCC's responsibilities. Each time HCC collects and uses Personal Data, it does so in the context of the implementation of the main public mission and its purposes, that is, to be able to answer your questions and communicate with you about anything else related to HCC's activities.
HCC will not disclose to any third party and will not use your Personal Data in cooperation with it, unless you have clear consent. Read more here.
